Cision PR Newswire

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...

GIGABYTE Showcases Practical AI TOP Utility for Local AI Applications at CES 2026

TAIPEI, Jan. 16, 2026 /PRNewswire/ -- As artificial intelligence continues to move from experimentation toward real-world adoption, GIGABYTE presents a clear local AI solution...

Infobip strengthens leadership to drive growth and innovation

Infobip announces key leadership changes with promotions of internal executives, effective 1 January 2026 KUALA LUMPUR, Malaysia, Jan. 16, 2026 /PRNewswire/ -- Global...

ZWIE and The Education University of Hong Kong Sign Memorandum of Cooperation to Promote Exchange and Deepen Collaboration

GUANGZHOU, China, Jan. 15, 2026 /PRNewswire/ -- On January 14, 2026, Guangzhou Zhongshan Whampoa School for Hong Kong and Macao Students (ZWIS) and Foshan Zhongshan...